The Aventis-Sanofi Merger: Role of French Government?
|
Case Code: BSTR116 Case Length: 17 Pages Period: 1998-2004 Pub Date: 2004 Teaching Note: Not Available |
Price: Rs.500 Organization: Aventis SA and Sanofi SA Industry: Pharmaceutical Countries: France Themes: Mergers Acquisition and Takeovers |
Abstract Case Intro 1 Case Intro 2 Excerpts
Abstract
The case gives a detailed account of the events that led to the merger of two of France's leading pharmaceutical companies, Aventis and Sanofi, to form the third largest pharma company in the world. It examines the efforts made by Aventis to prevent a hostile takeover attempt by Sanofi. The case also details the role played by the French government to prevent a possible merger between Swiss-based pharmaceutical company, Novartis and Aventis.
Issues
The case is structured to achieve the following teaching objectives:
- Merger & Acquisition, Hostile Takeover, Takeover Defense Strategies
Contents
-
Introduction
Background Note
The Acquisition Bid
The Takeover Battle
Enters French Government
Exhibits
Keywords
Aventis SA, Sanofi-Synthelabo SA, Novartis AG, French Pharma Industry, Politics and Business Environment, Merger & Acquisition, Hostile Takeover, Takeover Defense Strategies, French Takeover Regulations, Trends in European Pharma Industry, White Knight
Buy this case study (Please select any one of the payment options)
| Price: Rs.500 |
Price: Rs.500 | PayPal (11 USD) |
